Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Douglas J. Swirsky

Douglas J. Swirsky is recorded as Chairman and Board Member at Cellectar Biosciences, Inc. (CLRB). Cellectar Biosciences, Inc. reported in an 8-K filed July 10, 2026 that Douglas J. Swirsky was appointed Class III director, effective July 7, 2026. Cellectar Biosciences, Inc. reported in an 8-K filed June 29, 2023 that Douglas J. Swirsky was appointed Class III director, effective June 23, 2023.

“Class III directors, Andrew Gu and Douglas J. Swirsky, were nominated and elected to serve three-year terms.”
Cellectar Biosciences, Inc. Form 8-K, filed July 10, 2026 · Read the filing
“Class III directors, Stefan D. Loren, Ph.D. and Douglas J. Swirsky, were nominated and elected to serve three-year terms.”
Cellectar Biosciences, Inc. Form 8-K, filed June 29, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cellectar Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.